BNP Paribas Financial Markets’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1	Closed	-$3	–	4318
2020 Q2	$3	Sell	1 -18	-95%	-$104	﹤0.01%	4292
2020 Q1	$72	Hold	19	–	–	﹤0.01%	4227
2019 Q4	$122	Sell	19 -384	-95%	-$4.88K	﹤0.01%	4324
2019 Q3	$5.65K	Hold	403	–	–	﹤0.01%	4255
2019 Q2	$5.95K	Sell	403 -334	-45%	-$8.95K	﹤0.01%	4214
2019 Q1	$30.9K	Buy	737 +688	+1,404%	+$29K	﹤0.01%	3762
2018 Q4	$2.05K	Sell	49 -42	-46%	-$1.89K	﹤0.01%	3796
2018 Q3	$4.37K	Hold	91	–	–	﹤0.01%	4112
2018 Q2	$4.3K	Buy	+91	New	+$5.05K	﹤0.01%	4136

Other funds holding FSTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

BNP Paribas Financial Markets's FSTX Position: Q3 2020 in Review

BNP Paribas Financial Markets sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2020, closing a stake of 1 share — an estimated $3 sold.

BNP Paribas Financial Markets first reported a position in FSTX in Q2 2018 and held it in 9 quarters. The position peaked at $30.9K in Q1 2019. 23 funds tracked by Wall St. Rank hold FSTX as of Q3 2020.

BNP Paribas Financial Markets reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
BNP Paribas Financial Markets sold 1 F-star Therapeutics, Inc. Common Stock share in Q3 2020, an estimated $3.
BNP Paribas Financial Markets first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
BNP Paribas Financial Markets's F-star Therapeutics, Inc. Common Stock position peaked at $30.9K in Q1 2019.
23 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.